Tazobactam selects for multidrug resistance
Abstract Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination that is amongst the most prescribed antimicrobials in hospital medicine. Piperacillin is inactivated by many common beta-lactamases, but tazobactam inhibits these, allowing successful treatment. The effect of piperacill...
Saved in:
| Main Authors: | Emma R. Holden, Muhammad Yasir, A. Keith Turner, Ian G. Charles, Mark A. Webber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Antimicrobials and Resistance |
| Online Access: | https://doi.org/10.1038/s44259-025-00122-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of ceftolozane/tazobactam resistance in Pseudomonas aeruginosa isolates from South Korea
by: Yu Mi Wi, et al.
Published: (2024-12-01) -
The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa
by: Aviv Barzilai, et al.
Published: (2024-12-01) -
Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
by: Tuğba Pamukçu, et al.
Published: (2024-12-01) -
Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
by: Aikaterini Kyriakou, et al.
Published: (2019-01-01) -
Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01)